ASAM Education

ASAM Practice Pearls

Health EN ↓ 33 episodes

Join ASAM Practice Pearls for in-depth discussions on addiction prevention, treatment, and recovery. Geared toward healthcare professionals and individuals seeking knowledge, this series explores the latest evidence-based approaches to addiction medicine. Listen to interviews with leading experts as they delve into critical topics and share practical tools you can use to improve patient care and promote public health.

Author

ASAM Education

Episodes

Ketamine Infusion Therapy for Addiction Treatment: The Whys and Hows, The Dos and Don'ts 17.03.2025 34:45

In this episode of ASAM Practice Pearls, Dr. Stephen Taylor and Dr. Brent Boyett explore the potential of ketamine in addiction treatment. They discuss its history, mechanism of action, current research, clinical applications, risks, and future outlook. The episode offers valuable insights into ketamine’s role in addiction treatment while considering safety and its impact within the biopsychosocia...

Overcoming Barriers to MOUD at Discharge: Ensuring Continuity of Care from Skilled Nursing Facilities 03.03.2025 27:48

EP 01 🎙 Special Series: Advances in Buprenorphine Education This episode is part of a special series on improving hospital and clinic-based buprenorphine treatment for opioid use disorder. In this episode of ASAM Practice Pearls, Dr. Stephen Holt is joined by addiction medicine experts Dr. Carolyn Chan and Dr. Shawn Cohen. They explore key challenges and solutions in ensuring continuity of care...

Creating Realistic Follow-Up Plans for Unstable Patients 03.03.2025 28:24

EP 02 🎙 Special Series: Advances in Buprenorphine Education This episode is part of a special series on improving hospital and clinic-based buprenorphine treatment for opioid use disorder. In this episode of ASAM Practice Pearls, Dr. Shawn Cohen is joined by addiction medicine experts Dr. Carolyn Chan and Dr. Stephen Holt. Together, they explore effective strategies for managing unstable patient...

Balancing Patient Confidentiality and Legal Obligations 03.03.2025 36:44

EP 03 🎙 Special Series: Advances in Buprenorphine Education This episode is part of a special series on improving hospital and clinic-based buprenorphine treatment for opioid use disorder. In this episode of ASAM Practice Pearls, Dr. Stephen Holt and Dr. Shawn Cohen welcome addiction medicine expert Dr. Catherine Trimbur. They explore the delicate balance between protecting patient confidentiali...

Managing In-Hospital Substance Use 03.03.2025 30:50

EP 04 🎙 Special Series: Advances in Buprenorphine Education This episode is part of a special series on improving hospital and clinic-based buprenorphine treatment for opioid use disorder. In this episode of ASAM Practice Pearls, Dr. Carolyn Chan and Dr. Shawn Cohen welcome addiction medicine expert Dr. Marlene Martin. With extensive experience in helping care teams navigate the complexities of...

Tackling Tobacco Use Disorder: Challenges, Innovations, and E-Cigarettes 17.02.2025 24:40

In this episode of ASAM Practice Pearls, Dr. Peter Selby and Dr. Nancy Rigotti explore current and emerging strategies for treating tobacco use disorder (TUD). They discuss the latest pharmacological interventions, behavioral approaches, harm reduction strategies, and the evolving role of e-cigarettes in smoking cessation. ----more---- Looking for this episode's transcript? Download it HERE Have...

Treating Stimulant Use Disorder: Guidelines and Challenges 03.02.2025 32:14

In this episode of ASAM Practice Pearls, Dr. Stephen Taylor and Dr. Brian Hurley discuss the complexities of stimulant use disorder (StUD). Topics include challenges in managing StUD without FDA-approved medications, the impact of socioeconomic and cultural factors, and practical insights from the ASAM/AAAP guidelines. ----more---- Looking for this episode's transcript? Download it HERE Have an...

GLP-1 Receptor Agonists Explained: Their Potential Role in Addiction Treatment 22.01.2025 20:36

In this episode of ASAM Practice Pearls, Dr. Stephen Taylor hosts Dr. Stephanie Weiss from the National Institute on Drug Abuse (NIDA) to explore the potential of GLP-1 receptor agonists (GLP-1RA), particularly semaglutide, in treating alcohol use disorder. They discuss the underlying science, current research, and the challenges and implications of integrating these innovative treatments into add...